Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; The National Forensic Laboratory Information System Collection of Analysis Data, 47523 [2021-18276]
Download as PDF
Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices
DEPARTMENT OF JUSTICE
[OMB Number 1117–0034]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Revision of a
Previously Approved Collection; The
National Forensic Laboratory
Information System Collection of
Analysis Data
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget for review and
approval in accordance with the
Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
October 25, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Scott A. Brinks, Diversion
Control Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (571) 362–3261.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:54 Aug 24, 2021
Jkt 253001
Overview of This Information
Collection
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
1. Type of Information Collection:
Revision of a currently approved
collection.
2. Title of the Form/Collection: The
National Forensic Laboratory
Information System Collection of
Analysis Data.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
There are no form numbers for the
collection. The applicable component
within the Department of Justice is the
Drug Enforcement Administration,
Diversion Control Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Forensic
Science Laboratory Management.
Affected public (Other): None.
Abstract: This collection provides the
Drug Enforcement Administration
(DEA) with a national database on
analyzed drug evidence from nonfederal laboratories. Information from
this database is combined with the other
existing databases to develop more
accurate, up-to-date information on
abused drugs. This database represents
a voluntary, cooperative effort on the
part of participating laboratories to
provide a centralized source of analyzed
drug data.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that 2,640
persons annually for this collection at
2.2015 hour per respondent, for an
annual burden of 5,812 hours.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
this collection takes 5,812 annual
burden hours.
If additional information is required,
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
[Notice (21–055)]
Dated: August 20, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2021–18276 Filed 8–24–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
47523
Aerospace Safety Advisory Panel;
Meeting.
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
National Aeronautics and Space
Administration announces a
forthcoming meeting of the Aerospace
Safety Advisory Panel (ASAP).
DATES: Thursday, September 23, 2021,
2:00 p.m. to 3:30 p.m., Eastern Time.
ADDRESSES: This will be a virtual
meeting via teleconference.
FOR FURTHER INFORMATION CONTACT: Ms.
Lisa M. Hackley, ASAP Administrative
Officer, NASA Headquarters,
Washington, DC 20546, (202) 358–1947
or lisa.m.hackley@nasa.gov.
SUPPLEMENTARY INFORMATION: The
Aerospace Safety Advisory Panel
(ASAP) will hold its Fourth Quarterly
Meeting for 2021. This discussion is
pursuant to carrying out its statutory
duties for which the Panel reviews,
identifies, evaluates, and advises on
those program activities, systems,
procedures, and management activities
that can contribute to program risk.
Priority is given to those programs that
involve the safety of human flight. The
agenda will include:
—Updates on the International Space
Station Program
—Updates on the Commercial Crew
Program
—Updates on Exploration System
Development Program
—Updates on Human Lunar Exploration
Program
—NASA’s Human Flight Evolution
This meeting is a virtual meeting, and
only available telephonically. Any
interested person may call the USA toll
free conference call number 888–566–
6133; passcode 8343253 and then the #
sign. At the beginning of the meeting,
members of the public may make a
verbal presentation to the Panel on the
subject of safety in NASA, not to exceed
5 minutes in length. To do so, members
of the public must contact Ms. Lisa M.
Hackley at lisa.m.hackley@nasa.gov or
at (202) 358–1947 at least 48 hours in
advance. Any member of the public is
permitted to file a written statement
with the Panel via electronic submission
to Ms. Hackley at the email address
previously noted. Verbal presentations
and written statements should be
SUMMARY:
E:\FR\FM\25AUN1.SGM
25AUN1
Agencies
[Federal Register Volume 86, Number 162 (Wednesday, August 25, 2021)]
[Notices]
[Page 47523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18276]
[[Page 47523]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0034]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Revision of a Previously Approved Collection; The
National Forensic Laboratory Information System Collection of Analysis
Data
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget for review
and approval in accordance with the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and will be accepted for 60 days until
October 25, 2021.
FOR FURTHER INFORMATION CONTACT: If you have comments, especially on
the estimated public burden or associated response time, suggestions,
or need a copy of the proposed information collection instrument with
instructions or additional information, please contact Scott A. Brinks,
Diversion Control Division, Drug Enforcement Administration; Mailing
Address: 8701 Morrissette Drive, Springfield, Virginia 22152;
Telephone: (571) 362-3261.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Revision of a currently approved
collection.
2. Title of the Form/Collection: The National Forensic Laboratory
Information System Collection of Analysis Data.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: There are no form numbers for
the collection. The applicable component within the Department of
Justice is the Drug Enforcement Administration, Diversion Control
Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Forensic Science Laboratory Management.
Affected public (Other): None.
Abstract: This collection provides the Drug Enforcement
Administration (DEA) with a national database on analyzed drug evidence
from non-federal laboratories. Information from this database is
combined with the other existing databases to develop more accurate,
up-to-date information on abused drugs. This database represents a
voluntary, cooperative effort on the part of participating laboratories
to provide a centralized source of analyzed drug data.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 2,640 persons annually for this collection at 2.2015 hour per
respondent, for an annual burden of 5,812 hours.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates this collection takes
5,812 annual burden hours.
If additional information is required, please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: August 20, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2021-18276 Filed 8-24-21; 8:45 am]
BILLING CODE 4410-09-P